[HTML][HTML] Severe COVID-19: NLRP3 inflammasome dysregulated
DF Van den Berg, AA Te Velde - Frontiers in immunology, 2020 - frontiersin.org
SARS-CoV-2 might directly activate NLRP3 inflammasome resulting in an endogenous
adjuvant activity necessary to mount a proper adaptive immune response against the virus …
adjuvant activity necessary to mount a proper adaptive immune response against the virus …
[HTML][HTML] Targeting the NLRP3 inflammasome in severe COVID-19
TL Freeman, TH Swartz - Frontiers in immunology, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the genus
Betacoronavirus within the family Coronaviridae. It is an enveloped single-stranded positive …
Betacoronavirus within the family Coronaviridae. It is an enveloped single-stranded positive …
[HTML][HTML] NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
NLRP3 inflammasome is a critical immune component that plays a crucial role in mounting
innate immune responses. The deleterious effects of inflammasome activation have been …
innate immune responses. The deleterious effects of inflammasome activation have been …
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation
TS Rodrigues, DS Zamboni - Current Opinion in Immunology, 2023 - Elsevier
Highlights•SARS-CoV-2 infection in vitro triggers activation of the NLRP3
inflammasome.•The NLRP3 is activated in mice infected with SARS-CoV-2 and in the lungs …
inflammasome.•The NLRP3 is activated in mice infected with SARS-CoV-2 and in the lungs …
[HTML][HTML] Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
J Zeng, X Xie, XL Feng, L Xu, JB Han, D Yu, QC Zou… - …, 2022 - thelancet.com
Summary Background The Coronavirus Disease 2019 (COVID-19) pandemic has been a
great threat to global public health since 2020. Although the advance on vaccine …
great threat to global public health since 2020. Although the advance on vaccine …
[HTML][HTML] Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
A hyperinflammatory response during severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection crucially worsens clinical evolution of coronavirus disease 2019 …
(SARS-CoV-2) infection crucially worsens clinical evolution of coronavirus disease 2019 …
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
Dysregulated immune response is the key factor leading to unfavorable coronavirus disease
2019 (COVID-19) outcome. Depending on the pathogen-associated molecular pattern, the …
2019 (COVID-19) outcome. Depending on the pathogen-associated molecular pattern, the …
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
N Zhao, B Di, L Xu - Cytokine & growth factor reviews, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations …
syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations …
[HTML][HTML] Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
M Yalcinkaya, W Liu, MN Islam, AG Kotini… - Scientific reports, 2021 - nature.com
Despite the initial success of some drugs and vaccines targeting COVID-19, understanding
the mechanism underlying SARS-CoV-2 disease pathogenesis remains crucial for the …
the mechanism underlying SARS-CoV-2 disease pathogenesis remains crucial for the …
[HTML][HTML] Common NLRP3 inflammasome inhibitors and Covid-19: divide and conquer
Severe SARS-CoV-2 infection causes systemic inflammation, cytokine storm, and
hypercytokinemia due to activation of the release of pro-inflammatory cytokines that have …
hypercytokinemia due to activation of the release of pro-inflammatory cytokines that have …
相关搜索
- covid 19 nlrp3 inflammasome
- sars cov nlrp3 inflammasome
- interleukin 1 nlrp3 inflammasome
- covid 19 interleukin 1
- pathology in mice nlrp3 inflammasome
- envelope protein nlrp3 inflammasome
- covid 19 pathology in mice
- covid 19 myeloid cells
- therapeutic strategies nlrp3 inflammasome
- covid 19 therapeutic strategies
- covid 19 disease severity
- covid 19 risk factors
- covid 19 inflammasome inhibitors
- sars cov inflammasome activation
- therapeutic implications nlrp3 inflammasome
- covid 19 therapeutic implications